Optimizing Biomarkers and Endpoints in Oral Cancer Chemoprevention Trials

Por William, William N., Papadimitrakopoulou, Vassiliki A.
Publicado em 2013

Targeting the Epidermal Growth Factor Receptor for Head and Neck Cancer Chemoprevention

Por Mak, Milena P., William, William N.
Publicado em 2014

A Novel Target for Oral Cancer Chemoprevention? Notch Quite, Yet…

Por William, William N., El-Naggar, Adel K.
Publicado no Cancer Prev Res (Phila) (2015)

The Role of Systemic Treatment Before, During, and After Definitive Treatment

Por Gold, Kathryn A., Neskey, Michele, William, William N.
Publicado em 2013

Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention

Por Monteiro de Oliveira Novaes, Jose Augusto, William, William N
Publicado no Future Oncol (2016)

EVALUASI SISTEM INFORMASI PENJUALAN PADA PT ARORI JAYA

Por Anderes Gui, Maryanie Maryanie, Melvin Octorian, Nurhadi Nurhadi, William William
Publicado em 2009-10-01

Oral Premalignancy: The Roles of Early Detection and Chemoprevention

Por Foy, Jean-Philippe, Bertolus, Chloé, William, William N., Saintigny, Pierre
Publicado em 2013

Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories

Por Dahlstrom, Kristina R., Garden, Adam S., William, William N., Lim, Ming Yann, Sturgis, Erich M.
Publicado no J Clin Oncol (2016)

Sleep-Related Breathing Disorders in Patients With Tumors in the Head and Neck Region

Por Faiz, Saadia A., Balachandran, Diwakar, Hessel, Amy C., Lei, Xiudong, Beadle, Beth M., William, William N., Bashoura, Lara
Publicado no Oncologist (2014)

Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion

Por El Haddad, Danielle, Iliescu, Cezar, Yusuf, Syed Wamique, William, William Nassib, Khair, Tarif H., Song, Juhee, Mouhayar, Elie N.
Publicado no J Am Coll Cardiol (2015)

Relationship between level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma

Por Xing, Yan, Zhang, Jianjun, Lin, Heather, Gold, Kathryn A., Sturgis, Erich M., Garden, Adam S., Lee, J. Jack, William, William N.
Publicado no Cancer (2015)

Relationship between tumor size and survival in non-small cell lung cancer (NSCLC): an analysis of the Surveillance, Epidemiology, and End Results (SEER) registry

Por Zhang, Jianjun, Gold, Kathryn A., Lin, Heather Y., Swisher, Stephen G., Xing, Yan, Lee, J. Jack, Kim, Edward S., William, William N.
Publicado no J Thorac Oncol (2015)

Barriers to a Career Focus in Cancer Prevention: A Report and Initial Recommendations From the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group

Por Fabian, Carol J., Meyskens, Frank L., Bajorin, Dean F., George, Thomas J., Jeter, Joanne M., Khan, Shakila, Tyne, Courtney A., William, William N.
Publicado no J Clin Oncol (2016)

Phase II Chemoprevention Trial with High Dose Fenretinide for Oral Pre-Malignant Lesions

Por William, William N., Lee, J. Jack, Lippman, Scott M., Martin, Jack W., Tran, Hai T., Sabichi, Anita L., Kim, Edward S., Feng, Lei, Papadimitrakopoulou, Vassiliki A.
Publicado em 2009

Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

Por William, William N., Khuri, Fadlo R., Fossella, Frank V., Glisson, Bonnie S., Zinner, Ralph G., Lee, J. Jack, Herbst, Roy S., Lippman, Scott M., Kim, Edward S.
Publicado no Am J Clin Oncol (2010)

Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors

Por William, William N., Lee, Joseph L., Shin, Dong M., Hong, Waun K., Liu, Suyu, Lee, J. Jack, Lippman, Scott M., Khuri, Fadlo R., Kim, Edward S.
Publicado no Am J Clin Oncol (2009)

Phase 2 Study of Carboplatin, Docetaxel, and Bevacizumab as Frontline Treatment for Advanced Nonsmall-Cell Lung Cancer

Por William, William N., Kies, Merrill S., Fossella, Frank V., Liu, Diane D., Gladish, Gregory, Tse, Warner H., Lee, J. Jack, Hong, Waun K., Lippman, Scott M., Kim, Edward S.
Publicado no Cancer (2010)

Pathologic response after neoadjuvant chemotherapy in resectable non-small cell lung cancers: proposal for the use of “major pathologic response” as a surrogate endpoint

Por Hellmann, Matthew D., Chaft, Jamie E., William, William N., Rusch, Valerie, Pisters, Katherine M.W., Kalhor, Neda, Pataer, Apar, Travis, William D., Swisher, Stephen G., Kris, Mark G.
Publicado no Lancet Oncol (2014)

Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial

Por Hui, David, Kilgore, Kelly, Frisbee-Hume, Susan, Park, Minjeong, Tsao, Anne, Guay, Marvin Delgado, Lu, Charles, William, William, Pisters, Katherine, Eapen, George, Fossella, Frank, Amin, Sapna, Bruera, Eduardo
Publicado no J Pain Symptom Manage (2016)

A Phase 2 Study of Cetuximab in Combination With Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Nonsmall Cell Lung Cancer

Por Kim, Edward S., Mauer, Ann M., William, William N., Tran, Hai T., D, Pharm, Liu, Diane, Lee, Jack J., Windt, Paul, D, Pharm, Hong, Waun K., Vokes, Everett E., Herbst, Roy S.
Publicado no Cancer (2009)